Cargando…

Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells

Lisdexamfetamine dimesylate (LDX) is approved as a once-daily treatment for attention-deficit/hyperactivity disorder in children, adolescents, and adults in some countries. LDX is a prodrug comprising d-amphetamine covalently linked to l-lysine via a peptide bond. Following oral administration, LDX...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharman, Johannah, Pennick, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257105/ https://www.ncbi.nlm.nih.gov/pubmed/25489246 http://dx.doi.org/10.2147/NDT.S70382

Ejemplares similares

Metabolism of the prodrug lisdexamfetamine dimesylate in human red blood cells from normal and sickle cell disease donors*
por: Pennick, Michael
Publicado: (2013)

Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy
por: Ermer, James C., et al.
Publicado: (2016)

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
por: Pennick, Michael
Publicado: (2010)

Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs
por: Giordani, Federica, et al.
Publicado: (2020)

Altered Activity and Expression of Cytosolic Peptidases in Colorectal Cancer
por: Perez, Itxaro, et al.
Publicado: (2015)

Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly
por: Fu, Q., et al.
Publicado: (2015)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine
por: Jian-min, Chen, et al.
Publicado: (2022)

Dipeptidyl Peptidase IV as a Potential Target for Selective Prodrug Activation and Chemotherapeutic Action in Cancers
por: Dahan, Arik, et al.
Publicado: (2014)

A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
por: Coghill, David R., et al.
Publicado: (2014)

Update on optimal use of lisdexamfetamine in the treatment of ADHD
por: Madaan, Vishal, et al.
Publicado: (2013)

Potential for Dependence on Lisdexamfetamine - In vivo and In vitro Aspects
por: Yun, Jaesuk, et al.
Publicado: (2017)

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges
por: López, Frank A., et al.
Publicado: (2013)

Involvement of Carboxylesterase in Hydrolysis of Propranolol Prodrug during Permeation across Rat Skin
por: Imai, Teruko, et al.
Publicado: (2013)

Cytosolic Extract Induces Tir Translocation and Pedestals in EPEC-Infected Red Blood Cells
por: Swimm, Alyson I, et al.
Publicado: (2008)

A Chemical-Intervention Strategy To Circumvent Peptide Hydrolysis by d-Stereoselective Peptidases
por: Bann, Samantha J., et al.
Publicado: (2019)

Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
por: Roesch, Benno, et al.
Publicado: (2013)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
por: Burleigh, Tara, et al.
Publicado: (2020)

Lisdexamfetamine: Bilateral acute angle closure: case report
Publicado: (2021)

Co-Prodrugs of 7-Ethyl-10-hydroxycamptothecin and Vorinostat with in Vitro Hydrolysis and Anticancer Effects
por: Liu, Shuangxi, et al.
Publicado: (2019)

In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir
por: Zhang, Qingchen, et al.
Publicado: (2022)

Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas
por: Chang, Shih-Jen, et al.
Publicado: (2022)

Relative Bioavailabilities of Lisdexamfetamine Dimesylate and d-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink
por: Ermer, James, et al.
Publicado: (2016)

Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
por: Maneeton, Narong, et al.
Publicado: (2014)

Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
por: Najib, Jadwiga
Publicado: (2012)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
por: Najib, Jadwiga, et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Unexpected Stability of a Prodrug to Enzymatic Hydrolysis within a Hydrated HPMC Matrix Tablet
por: Hanley, Sarah, et al.
Publicado: (2022)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Muscarinic receptor-induced phosphoinositide hydrolysis at resting cytosolic Ca2+ concentration in PC12 cells
Publicado: (1985)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

A Mechanistic View of Enzyme Inhibition and Peptide Hydrolysis in the Active Site of the SARS-CoV 3C-like Peptidase
por: Yin, Jiang, et al.
Publicado: (2007)

Complex of Proline-Specific Peptidases in the Genome and Gut Transcriptomes of Tenebrionidae Insects and Their Role in Gliadin Hydrolysis
por: Tereshchenkova, Valeriia F., et al.
Publicado: (2022)

Restriction of cytosolic sucrose hydrolysis profoundly alters development, metabolism, and gene expression in Arabidopsis roots
por: Pignocchi, Cristina, et al.
Publicado: (2020)

Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
por: Adler, Lenard A, et al.
Publicado: (2009)

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
por: Guerdjikova, Anna I, et al.
Publicado: (2016)

The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA
por: Ágh, Tamás, et al.
Publicado: (2016)

Use of Lisdexamfetamine to Treat Obesity in an Adolescent with Severe Obesity and Binge Eating
por: Srivastava, Gitanjali, et al.
Publicado: (2019)

Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B(2) receptor and peptidase resistance in rats
por: Charest-Morin, Xavier, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dlpaaov5krlfefot17676msfui